位置:首页 > 蛋白库 > SYV_FUSNN
SYV_FUSNN
ID   SYV_FUSNN               Reviewed;         887 AA.
AC   Q8RHK3;
DT   07-MAR-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2002, sequence version 1.
DT   03-AUG-2022, entry version 112.
DE   RecName: Full=Valine--tRNA ligase {ECO:0000255|HAMAP-Rule:MF_02004};
DE            EC=6.1.1.9 {ECO:0000255|HAMAP-Rule:MF_02004};
DE   AltName: Full=Valyl-tRNA synthetase {ECO:0000255|HAMAP-Rule:MF_02004};
DE            Short=ValRS {ECO:0000255|HAMAP-Rule:MF_02004};
GN   Name=valS {ECO:0000255|HAMAP-Rule:MF_02004}; OrderedLocusNames=FN2011;
OS   Fusobacterium nucleatum subsp. nucleatum (strain ATCC 25586 / DSM 15643 /
OS   BCRC 10681 / CIP 101130 / JCM 8532 / KCTC 2640 / LMG 13131 / VPI 4355).
OC   Bacteria; Fusobacteria; Fusobacteriales; Fusobacteriaceae; Fusobacterium.
OX   NCBI_TaxID=190304;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 25586 / DSM 15643 / BCRC 10681 / CIP 101130 / JCM 8532 / KCTC
RC   2640 / LMG 13131 / VPI 4355;
RX   PubMed=11889109; DOI=10.1128/jb.184.7.2005-2018.2002;
RA   Kapatral V., Anderson I., Ivanova N., Reznik G., Los T., Lykidis A.,
RA   Bhattacharyya A., Bartman A., Gardner W., Grechkin G., Zhu L., Vasieva O.,
RA   Chu L., Kogan Y., Chaga O., Goltsman E., Bernal A., Larsen N., D'Souza M.,
RA   Walunas T., Pusch G., Haselkorn R., Fonstein M., Kyrpides N.C.,
RA   Overbeek R.;
RT   "Genome sequence and analysis of the oral bacterium Fusobacterium nucleatum
RT   strain ATCC 25586.";
RL   J. Bacteriol. 184:2005-2018(2002).
CC   -!- FUNCTION: Catalyzes the attachment of valine to tRNA(Val). As ValRS can
CC       inadvertently accommodate and process structurally similar amino acids
CC       such as threonine, to avoid such errors, it has a 'posttransfer'
CC       editing activity that hydrolyzes mischarged Thr-tRNA(Val) in a tRNA-
CC       dependent manner. {ECO:0000255|HAMAP-Rule:MF_02004}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-valine + tRNA(Val) = AMP + diphosphate + L-valyl-
CC         tRNA(Val); Xref=Rhea:RHEA:10704, Rhea:RHEA-COMP:9672, Rhea:RHEA-
CC         COMP:9708, ChEBI:CHEBI:30616, ChEBI:CHEBI:33019, ChEBI:CHEBI:57762,
CC         ChEBI:CHEBI:78442, ChEBI:CHEBI:78537, ChEBI:CHEBI:456215; EC=6.1.1.9;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_02004};
CC   -!- SUBUNIT: Monomer. {ECO:0000255|HAMAP-Rule:MF_02004}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000255|HAMAP-Rule:MF_02004}.
CC   -!- DOMAIN: ValRS has two distinct active sites: one for aminoacylation and
CC       one for editing. The misactivated threonine is translocated from the
CC       active site to the editing site. {ECO:0000255|HAMAP-Rule:MF_02004}.
CC   -!- DOMAIN: The C-terminal coiled-coil domain is crucial for aminoacylation
CC       activity. {ECO:0000255|HAMAP-Rule:MF_02004}.
CC   -!- SIMILARITY: Belongs to the class-I aminoacyl-tRNA synthetase family.
CC       ValS type 1 subfamily. {ECO:0000255|HAMAP-Rule:MF_02004}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AE009951; AAL94101.1; -; Genomic_DNA.
DR   RefSeq; NP_602802.1; NC_003454.1.
DR   AlphaFoldDB; Q8RHK3; -.
DR   SMR; Q8RHK3; -.
DR   STRING; 190304.FN2011; -.
DR   PRIDE; Q8RHK3; -.
DR   EnsemblBacteria; AAL94101; AAL94101; FN2011.
DR   KEGG; fnu:FN2011; -.
DR   PATRIC; fig|190304.8.peg.479; -.
DR   eggNOG; COG0525; Bacteria.
DR   HOGENOM; CLU_001493_0_2_0; -.
DR   InParanoid; Q8RHK3; -.
DR   OMA; FATKLWN; -.
DR   BioCyc; FNUC190304:G1FZS-498-MON; -.
DR   Proteomes; UP000002521; Chromosome.
DR   GO; GO:0005829; C:cytosol; IBA:GO_Central.
DR   GO; GO:0002161; F:aminoacyl-tRNA editing activity; IEA:InterPro.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0004832; F:valine-tRNA ligase activity; IBA:GO_Central.
DR   GO; GO:0006438; P:valyl-tRNA aminoacylation; IBA:GO_Central.
DR   CDD; cd07962; Anticodon_Ia_Val; 1.
DR   Gene3D; 1.10.287.380; -; 1.
DR   Gene3D; 3.40.50.620; -; 2.
DR   HAMAP; MF_02004; Val_tRNA_synth_type1; 1.
DR   InterPro; IPR001412; aa-tRNA-synth_I_CS.
DR   InterPro; IPR002300; aa-tRNA-synth_Ia.
DR   InterPro; IPR033705; Anticodon_Ia_Val.
DR   InterPro; IPR013155; M/V/L/I-tRNA-synth_anticd-bd.
DR   InterPro; IPR014729; Rossmann-like_a/b/a_fold.
DR   InterPro; IPR010978; tRNA-bd_arm.
DR   InterPro; IPR009080; tRNAsynth_Ia_anticodon-bd.
DR   InterPro; IPR037118; Val-tRNA_synth_C_sf.
DR   InterPro; IPR019499; Val-tRNA_synth_tRNA-bd.
DR   InterPro; IPR009008; Val/Leu/Ile-tRNA-synth_edit.
DR   InterPro; IPR002303; Valyl-tRNA_ligase.
DR   PANTHER; PTHR11946; PTHR11946; 1.
DR   Pfam; PF08264; Anticodon_1; 1.
DR   Pfam; PF00133; tRNA-synt_1; 1.
DR   Pfam; PF10458; Val_tRNA-synt_C; 1.
DR   PRINTS; PR00986; TRNASYNTHVAL.
DR   SUPFAM; SSF46589; SSF46589; 1.
DR   SUPFAM; SSF47323; SSF47323; 1.
DR   SUPFAM; SSF50677; SSF50677; 1.
DR   TIGRFAMs; TIGR00422; valS; 1.
DR   PROSITE; PS00178; AA_TRNA_LIGASE_I; 1.
PE   3: Inferred from homology;
KW   Aminoacyl-tRNA synthetase; ATP-binding; Coiled coil; Cytoplasm; Ligase;
KW   Nucleotide-binding; Protein biosynthesis; Reference proteome.
FT   CHAIN           1..887
FT                   /note="Valine--tRNA ligase"
FT                   /id="PRO_0000224480"
FT   COILED          817..887
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_02004"
FT   MOTIF           45..55
FT                   /note="'HIGH' region"
FT   MOTIF           528..532
FT                   /note="'KMSKS' region"
FT   BINDING         531
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_02004"
SQ   SEQUENCE   887 AA;  103049 MW;  AE9F5FAC9757B3FE CRC64;
     MNELDKNYSP NEIEEKWYKI WEDSKYFAAS LSSEKENYSI VIPPPNVTGI LHMGHVLNNS
     IQDTLIRYNR MTGKNTLWMP GCDHAGIATQ NKVERKLAED GLKKEDIGRE KFLEMTWDWK
     EKYGGIITKQ LRKLGASLDW DRERFTMDEG LSYAVRKIFN DLYHDGLIYQ GEYMVNWCPS
     CGTALADDEV DHEEKDGHLW QIKYPVKDSD EYIIIATSRP ETMLADVAVA VHPEDERYKH
     LIGKTLILPL VNREIPVIAD EYVDKEFGTG ALKITPAHDP NDYNLGKKYN LPIINMLTPD
     GKIVEDYPKY AGLDRFEARK KIVEDLKAQD LFIKTEHLHH AVGQCYRCQT VIEPRVSPQW
     FVKMKPLAEK ALEVVRNGEV KILPKRMEKI YYNWLENIRD WCISRQIWWG HRIPAWYGPD
     RHVFVAMDEA EAKEQAKKHY GHDVELSQEE DVLDTWFSSA LWPFSTMGWP EKTKELDLFY
     PTNTLVTGAD IIFFWVARMI MFGMYELKKI PFKNVFFHGI VRDEIGRKMS KSLGNSPDPL
     DLIKEYGVDA IRFSMIYNTS QGQDVHFSTD LLGMGRNFAN KIWNATRFVI MNLKGFDVKS
     VDKTKLDYEL VDKWIISRLN ETAKDVKDCL EKFELDNAAK AVYEFLRGDF CDWYVEIAKI
     RLYNDDEDKK ISKLTAQYML WTILEQGLRL LHPFMPFITE EIWQKIKVDG DTIMLQQYPV
     ADDSLIDVKI EKSFEYIKEV VSSLRNIRAE KGISPAKPAK VVVSTSNSEE LETLEKNELF
     IKKLANLEEL TCGTDLEAPS QSSLRVAGNS SVYMILTGLL NNEAEIKKIN EQLAKLEKEL
     EPVNRKLSDE KFTSKAPQHI IDRELRIQKE YQDKIKKLKE SLKSFEE
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024